| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $11.2B | $12.1B | $12.5B | $15.8B | $11.8B | $2.0B | $1.9B | $2.0B |
| Cost of Revenue | $10.4B | $10.2B | $10.3B | $11.7B | $8.3B | $6.5B | $6.9B | $6.6B |
| Gross Profit | $0.8B | $2.0B | $2.2B | $4.1B | $3.5B | $0.3B | $0.3B | $0.4B |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | $0.9B | $0.9B | $0.9B | $0.8B | $0.6B | $0.4B | $0.5B | $0.4B |
| Operating Income | $-1.6B | $0.9B | $0.7B | $3.0B | $2.8B | $0.2B | $0.1B | $0.2B |
| Net Income | $-1.5B | $0.6B | $0.5B | $2.2B | $2.0B | $0.1B | $0.1B | $0.1B |
| EPS (Basic) | $-11.70 | $4.66 | $3.73 | $17.46 | $15.66 | $0.87 | $0.56 | $0.95 |
| EPS (Diluted) | $-11.70 | $4.64 | $3.70 | $17.34 | $15.58 | $0.87 | $0.56 | $0.95 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $20.0B | $20.8B | $21.0B | $20.6B | $18.5B | $13.8B | $13.3B | $11.6B |
| Current Assets | $6.2B | $6.2B | $6.6B | $6.0B | $5.3B | $3.5B | $2.7B | $2.8B |
| Cash & Equivalents | $2.7B | $2.9B | $3.3B | $2.2B | $1.9B | $1.3B | $0.7B | $0.8B |
| Total Liabilities | $10.7B | $9.7B | $10.3B | $10.1B | $9.9B | $7.3B | $6.9B | $5.5B |
| Current Liabilities | $2.8B | $2.2B | $2.8B | $2.3B | $2.3B | $1.4B | $1.2B | $1.2B |
| Stockholders' Equity | $8.8B | $10.5B | $10.2B | $9.9B | $8.0B | $6.0B | $5.9B | $5.6B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $0.5B | $1.3B | $2.3B | $3.4B | $2.4B | $1.3B | $1.3B | $1.4B |
| Investing Cash Flow | $-1.2B | $-1.0B | $-1.0B | $-2.5B | $-3.2B | $-0.5B | $-2.0B | $-0.8B |
| Capital Expenditures | $1.0B | $1.0B | $1.0B | $1.1B | $0.7B | $0.5B | $0.8B | $0.7B |
| Financing Cash Flow | $0.5B | $-0.7B | $-0.2B | $-0.6B | $1.4B | $-0.2B | $0.6B | $-1.4B |